Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.538 Q1 | 202 | 504 | 1001 | 59089 | 5168 | 970 | 4.57 | 117.24 | |
2 | Current Pharmaceutical Design | journal | 1.280 Q1 | 183 | 585 | 1163 | 65504 | 4819 | 1058 | 3.77 | 111.97 | |
3 | Current Topics in Medicinal Chemistry | journal | 1.409 Q1 | 133 | 233 | 510 | 22139 | 1975 | 440 | 3.77 | 95.02 | |
4 | Current Drug Targets | journal | 1.332 Q1 | 119 | 194 | 483 | 18772 | 1881 | 438 | 4.21 | 96.76 | |
5 | Current Organic Chemistry | journal | 1.406 Q1 | 112 | 193 | 491 | 17062 | 1536 | 448 | 2.98 | 88.40 | |
6 | Current Cancer Drug Targets | journal | 1.789 Q1 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | |
7 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q1 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | |
8 | Current Alzheimer Research | journal | 1.509 Q1 | 103 | 120 | 254 | 9914 | 1139 | 241 | 3.98 | 82.62 | |
9 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 108 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | |
10 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | |
11 | Current Vascular Pharmacology | journal | 0.975 Q1 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | |
12 | Current Gene Therapy | journal | 1.565 Q1 | 80 | 45 | 141 | 5121 | 693 | 127 | 5.30 | 113.80 | |
13 | Combinatorial Chemistry and High Throughput Screening | journal | 0.607 Q2 | 70 | 87 | 293 | 4972 | 632 | 261 | 1.99 | 57.15 | |
14 | Current Protein and Peptide Science | journal | 1.339 Q1 | 96 | 74 | 204 | 8257 | 600 | 179 | 2.23 | 111.58 | |
15 | Current Genomics | journal | 1.273 Q2 | 77 | 67 | 184 | 5787 | 595 | 175 | 3.01 | 86.37 | |
16 | Current Nanoscience | journal | 0.453 Q2 | 52 | 135 | 296 | 4918 | 504 | 292 | 1.52 | 36.43 | |
17 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | |
18 | Current Drug Delivery | journal | 0.804 Q1 | 72 | 64 | 183 | 3473 | 491 | 179 | 2.93 | 54.27 | |
19 | Current Stem Cell Research and Therapy | journal | 1.065 Q1 | 63 | 49 | 120 | 3616 | 471 | 114 | 3.33 | 73.80 | |
20 | Current Diabetes Reviews | journal | 1.034 Q2 | 68 | 49 | 129 | 5136 | 460 | 127 | 3.24 | 104.82 | |
21 | Current Neurovascular Research | journal | 0.991 Q2 | 60 | 41 | 96 | 1746 | 356 | 96 | 3.31 | 42.59 | |
22 | Letters in Drug Design and Discovery | journal | 0.284 Q2 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | |
23 | Medicinal Chemistry | journal | 0.402 Q3 | 50 | 139 | 199 | 4664 | 317 | 197 | 1.48 | 33.55 | |
24 | Letters in Organic Chemistry | journal | 0.301 Q3 | 33 | 132 | 403 | 3683 | 295 | 402 | 0.68 | 27.90 | |
25 | Current Molecular Pharmacology | journal | 1.560 Q1 | 49 | 39 | 59 | 3998 | 291 | 57 | 4.38 | 102.51 | |
26 | Current Drug Discovery Technologies | journal | 0.801 Q2 | 49 | 34 | 94 | 2615 | 288 | 87 | 2.45 | 76.91 | |
27 | Current Organic Synthesis | journal | 1.102 Q2 | 55 | 53 | 110 | 5470 | 284 | 101 | 1.94 | 103.21 | |
28 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | |
29 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.837 Q3 | 39 | 31 | 100 | 3330 | 273 | 91 | 2.09 | 107.42 | |
30 | Current Aging Science | journal | 1.029 Q1 | 42 | 36 | 82 | 1981 | 259 | 80 | 3.30 | 55.03 | |
31 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q1 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | |
32 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 34 | 98 | 2712 | 252 | 95 | 2.60 | 79.76 | ||
33 | Current Drug Safety | journal | 0.428 Q2 | 41 | 63 | 136 | 2743 | 228 | 124 | 1.49 | 43.54 | |
34 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.819 Q2 | 63 | 40 | 101 | 3682 | 226 | 97 | 1.69 | 92.05 | |
35 | Mini-Reviews in Organic Chemistry | journal | 0.635 Q2 | 43 | 41 | 120 | 2782 | 225 | 114 | 1.11 | 67.85 | |
36 | Current Cardiology Reviews | journal | 0.553 Q2 | 58 | 43 | 123 | 2889 | 219 | 117 | 1.56 | 67.19 | |
37 | Current Analytical Chemistry | journal | 0.479 Q3 | 38 | 59 | 115 | 2943 | 202 | 112 | 1.65 | 49.88 | |
38 | Current Proteomics | journal | 0.296 Q3 | 27 | 24 | 90 | 2070 | 189 | 83 | 0.81 | 86.25 | |
39 | Open Cardiovascular Medicine Journal | journal | 0.456 Q2 | 32 | 25 | 107 | 950 | 188 | 103 | 1.96 | 38.00 | |
40 | Reviews on Recent Clinical Trials | journal | 0.683 Q2 | 35 | 42 | 79 | 2507 | 186 | 79 | 2.00 | 59.69 | |
41 | Current Bioinformatics | journal | 0.238 Q4 | 38 | 53 | 87 | 3834 | 180 | 84 | 2.19 | 72.34 | |
42 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 55 | 2367 | 179 | 54 | 2.50 | 107.59 | ||
43 | Recent Patents on CNS Drug Discovery | journal | 0.803 Q2 | 36 | 25 | 58 | 3322 | 179 | 58 | 3.03 | 132.88 | |
44 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q2 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | |
45 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 27 | 65 | 2250 | 163 | 64 | 2.82 | 83.33 | ||
46 | Clinical Practice and Epidemiology in Mental Health | journal | 0.645 Q2 | 58 | 25 | 66 | 1220 | 149 | 64 | 2.00 | 48.80 | |
47 | Current Pharmaceutical Analysis | journal | 0.425 Q2 | 27 | 48 | 96 | 1591 | 147 | 95 | 1.50 | 33.15 | |
48 | Current Chemical Biology | journal | 0.378 Q2 | 26 | 27 | 80 | 2346 | 141 | 77 | 0.63 | 86.89 | |
49 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 22 | 79 | 2504 | 141 | 79 | 1.46 | 113.82 | ||
50 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q3 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®